564 related articles for article (PubMed ID: 28095864)
1. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
[TBL] [Abstract][Full Text] [Related]
2. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.
Wang B; Li X; Zhao G; Yan H; Dong P; Watari H; Sims M; Li W; Pfeffer LM; Guo Y; Yue J
J Exp Clin Cancer Res; 2018 Sep; 37(1):235. PubMed ID: 30241553
[TBL] [Abstract][Full Text] [Related]
3. Up-Regulation of miR-204 Enhances Anoikis Sensitivity in Epithelial Ovarian Cancer Cell Line Via Brain-Derived Neurotrophic Factor Pathway In Vitro.
Yan H; Wu W; Ge H; Li P; Wang Z
Int J Gynecol Cancer; 2015 Jul; 25(6):944-52. PubMed ID: 25962115
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-650 suppresses KLF12 expression to regulate growth and metastasis of human ovarian cancer cells.
Lu X; Han Y; Han Y; Huang M; You J; Liu Y; Ding Y; Zheng Y
Acta Biochim Pol; 2022 Oct; 69(4):745-751. PubMed ID: 36272152
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer.
Yu SJ; Hu JY; Kuang XY; Luo JM; Hou YF; Di GH; Wu J; Shen ZZ; Song HY; Shao ZM
Clin Cancer Res; 2013 Mar; 19(6):1389-99. PubMed ID: 23340296
[TBL] [Abstract][Full Text] [Related]
6. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ZFAS1 interacts with miR-150-5p to regulate Sp1 expression and ovarian cancer cell malignancy.
Xia B; Hou Y; Chen H; Yang S; Liu T; Lin M; Lou G
Oncotarget; 2017 Mar; 8(12):19534-19546. PubMed ID: 28099946
[TBL] [Abstract][Full Text] [Related]
8. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
9. Tumour-suppression function of KLF12 through regulation of anoikis.
Godin-Heymann N; Brabetz S; Murillo MM; Saponaro M; Santos CR; Lobley A; East P; Chakravarty P; Matthews N; Kelly G; Jordan S; Castellano E; Downward J
Oncogene; 2016 Jun; 35(25):3324-34. PubMed ID: 26455320
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-205 directly targets Krüppel-like factor 12 and is involved in invasion and apoptosis in basal-like breast carcinoma.
Guan B; Li Q; Shen L; Rao Q; Wang Y; Zhu Y; Zhou XJ; Li XH
Int J Oncol; 2016 Aug; 49(2):720-34. PubMed ID: 27278159
[TBL] [Abstract][Full Text] [Related]
11. Sp1 promotes ovarian cancer cell migration through repressing miR-335 expression.
Wang S; Li Y; Sun S; Cai J; Cao J
Biochem Biophys Res Commun; 2020 Mar; 524(1):211-216. PubMed ID: 31983431
[TBL] [Abstract][Full Text] [Related]
12. miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C.
Du Y; Chen Y; Wang F; Gu L
Tumour Biol; 2016 Oct; 37(10):13557-13569. PubMed ID: 27468717
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
He C; Wang L; Zhang J; Xu H
Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
[TBL] [Abstract][Full Text] [Related]
14. MiR-326/Sp1/KLF3: A novel regulatory axis in lung cancer progression.
Wang R; Xu J; Xu J; Zhu W; Qiu T; Li J; Zhang M; Wang Q; Xu T; Guo R; Lu K; Yin Y; Gu Y; Zhu L; Huang P; Liu P; Liu L; De W; Shu Y
Cell Prolif; 2019 Mar; 52(2):e12551. PubMed ID: 30485570
[TBL] [Abstract][Full Text] [Related]
15. Methylation-associated silencing of
Chen K; Liu MX; Mak CS; Yung MM; Leung TH; Xu D; Ngu SF; Chan KK; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(2):423-436. PubMed ID: 29290818
[TBL] [Abstract][Full Text] [Related]
16. Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.
Zeng X; Xu Z; Gu J; Huang H; Gao G; Zhang X; Li J; Jin H; Jiang G; Sun H; Huang C
Mol Cancer Ther; 2016 Mar; 15(3):512-22. PubMed ID: 26832795
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-6744-5p promotes anoikis in breast cancer and directly targets NAT1 enzyme.
Malagobadan S; Ho CS; Nagoor NH
Cancer Biol Med; 2020 Feb; 17(1):101-111. PubMed ID: 32296579
[No Abstract] [Full Text] [Related]
18. MicroRNA-22 suppresses the growth, migration and invasion of colorectal cancer cells through a Sp1 negative feedback loop.
Xia SS; Zhang GJ; Liu ZL; Tian HP; He Y; Meng CY; Li LF; Wang ZW; Zhou T
Oncotarget; 2017 May; 8(22):36266-36278. PubMed ID: 28422727
[TBL] [Abstract][Full Text] [Related]
19. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
20. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
Mao Y; Chen H; Lin Y; Xu X; Hu Z; Zhu Y; Wu J; Xu X; Zheng X; Xie L
Oncol Rep; 2013 Jul; 30(1):327-33. PubMed ID: 23670210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
